Cargando…
The Therapeutic Effect of Adding Dextromethorphan to Clonidine for Reducing Symptoms of Opioid Withdrawal: A Randomized Clinical Trial
Background. Dextromethorphan is a noncompetitive N-methyl D-aspartate receptor antagonist that is clinically feasible for relieving the opioid withdrawal symptoms. This study compares the efficacy of a combination therapy with dextromethorphan and clonidine to treatment with clonidine alone. Methods...
Autores principales: | Malek, Ayyoub, Amiri, Shahrokh, Habibi Asl, Bohlool |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706070/ https://www.ncbi.nlm.nih.gov/pubmed/23864983 http://dx.doi.org/10.1155/2013/546030 |
Ejemplares similares
-
Amantadine as Augmentation in Managing Opioid Withdrawal with Clonidine: a randomized controlled trial
por: Amiri, Shahrokh, et al.
Publicado: (2014) -
Managing Opioid Withdrawal in an Outpatient Setting With Lofexidine or Clonidine
por: Gripshover, Jeanne, et al.
Publicado: (2022) -
Effect of N-Methyl-D-Aspartate Receptor Antagonist Dextromethorphan on Opioid Analgesia in Pediatric Intensive Care Unit
por: Naeem, Mohammed, et al.
Publicado: (2016) -
CLONIDINE FOR OPIATE WITHDRAWAL
por: Subramanya,, et al.
Publicado: (1981) -
The Impact of Saffron on Symptoms of Withdrawal Syndrome in Patients Undergoing Maintenance Treatment for Opioid Addiction in Sabzevar Parish in 2017
por: Nemat Shahi, Mohammad, et al.
Publicado: (2017)